Xun, Xu,,
Liang, Yuan,
Gareev, Ilgiz,
Liang, Yanchao,
Liu, Rui,
Wang, Ning,
Yang, Guang (2023) and chemoradiotherapy resistance, we discussed the feasibility for lncRNAs as therapeutic
targets. Finally
Begliarzade, Sema,
Beilerli, Aferin,
Sufianov, Albert,
Tamrazov, Rasim,
Kudriashov, Valentin,
Ilyasova, Tatiana,
Liang, Yanchao,
Beylerli, Ozal (2023) tools, as well as to consider them as effective
therapeutic
targets in cervical cancer.
formation and their consideration as therapeutic
targets have been well studied. In this case, accurate
Transposable elements are important sources of miRNA, long non-coding RNAs genes,
and their
targetsUsman, M.,
Beilerli, A.,
Sufianov, A.,
Kudryashov, V.,
Ilyasova, T.,
Balaev, P.,
Danilov, A.,
Lu, H.,
Gareev, I. (2023) (lncRNAs) and circular
RNAs (circRNAs) into clinical medicine as biomarkers and therapeutic
targets.
Guan, Xiaoxiang,
Zhang, Yiwei,
Gareev, Ilgiz,
Beylerli, Ozal,
Li, Xinyuan,
Lu, Guitian,
Lv, Lin,
Hai, Xin (2023) MiR-499a prevents astrocytes mediated inflammation in ischemic stroke by
targeting PTEN
Sufianov, A.,
Kostin, A.,
Begliarzade, S.,
Kudriashov, V.,
Ilyasova, T.,
Liang, Y.,
Mukhamedzyanov, A.,
Beylerli, O. (2023) studies in clinical laboratories. In addition, the question of the
target orientation of exosomes
Gareev, Ilgiz,
Encarnacion Ramirez, Manuel de Jesus,
Nurmukhametov, Renat,
Ivliev, Denis,
Shumadalova, Alina,
Ilyasova, Tatiana,
Beilerli, Aferin,
Wang, Chunlei (2023) biomarkers and therapeutic
targets specifically tailored for glioma. In recent years, long non-coding RNAs